Caffeine Recruiting Phase 1 Trials for Hypoxic-Ischaemic Encephalopathy Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03913221Caffeine for Hypoxic-Ischemic Encephalopathy